Hypertension

>

Latest News

Aprocitentan Reduces BP in Black Adults with Resistant Hypertension and Lowers Proteinuria / image courtesy of Tulane U School of Medicine
Aprocitentan Reduces BP in Black Adults with Resistant Hypertension and Lowers Proteinuria

April 9th 2025

Aprocitentan, when added to background therapy of at least 3 antihypertensive agents, led to clinically meaningful and sustained BP reduction in this preplanned subanalysis.

Heart Disease Remains Leading Cause of Death in US: Daily Dose / image credit: ©New Africa/AdobeStock
Heart Disease Remains Leading Cause of Death in US: Daily Dose

February 11th 2025

Furosemide Fails to Reduce Risk of Dangerous de novo Postpartum Hypertension: New Research / image credit ©javier/stock.adobe.com
Furosemide Fails to Reduce Risk of Dangerous de novo Postpartum Hypertension: New Research

January 30th 2025

CVD Remains Leading Cause of Death in US: AHA 2025 Statistical Update / Image credit: ©Rasi/AdobeStock
CVD Remains Leading Cause of Death in US: AHA 2025 Statistical Update

January 27th 2025

Obstructive Sleep Apnea and Hypertension Update: FDA Clears Phase 2 Trial of Lorundrostat, an Oral Aldosterone Synthase Inhibitor
Obstructive Sleep Apnea and Hypertension Update: FDA Clears Phase 2 Trial of Lorundrostat, an Oral Aldosterone Synthase Inhibitor

January 17th 2025

Video Interviews
Podcasts

More News

© 2025 MJH Life Sciences

All rights reserved.